ALX Oncology Holdings, Inc. (ALXO)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
May 22, 16:00
1.985
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Total Assets (Quarterly) : 178.33M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| ADMA Biologics, Inc. | 665.18M |
| Biogen, Inc. | 29.48B |
| Aldeyra Therapeutics, Inc. | 66.48M |
| CytomX Therapeutics, Inc. | 359.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.98M |
| Shareholders Equity (Quarterly) | 151.35M |
| Debt to Equity Ratio | 0.0862 |
| Current Ratio | 7.214 |
| Net Debt Paydown Yield | 0.29% |